Outcomes in COVID-19 Patients with Pneumonia Treated with High-Flow Oxygen Therapy and Baricitinib-Retrospective Single-Center Study.
Dušanka ObradovićMilica PopovićMaja BanjacJelena BulajićVladimir ĐurovićIvana UroševićAleksandra MilovančevPublished in: Life (Basel, Switzerland) (2023)
Treatment with baricitinib in addition to SOC was associated with reduced mortality and a lower prevalence of transfer to the ICU in hospitalized patients with COVID-19 pneumonia treated with high-flow oxygen non-invasive therapy.